Veterans With Mesothelioma Receive Up to $4,158 a Month Under 2026 VA Rates
Under the 2026 VA rates, a veteran rated 100% for mesothelioma receives $3,938.58 a month alone or $4,158.17 with a spouse, a 2.8% increase.
News & Research
280 articles
Latest mesothelioma updates and data-driven research from peer-reviewed sources
Latest News
legal EPA's Chrysotile Asbestos Ban Stays in Effect as the Fifth Circuit Weighs Industry Challenge
legal Talc Now Appears in About 1 in 3 US Mesothelioma Lawsuits
clinical-trials Oral Alintegimod (7HP349) Trial Adds Mesothelioma to Its Cohorts
clinical-trials Italian Imaging-Meso Study Maps the Mesothelioma Immune Map
clinical-trials MDNA11 IL-2 Superkine Trial Includes Pleural Mesothelioma
clinical-trials Rina-S Trial Adds Mesothelioma to Its Tumor Cohorts
clinical-trials TNG462 Trial: PRMT5 Inhibitor for MTAP-Deleted Mesothelioma
clinical-trials STEALTH-001 Trial Tests VET3-TGI Oncolytic Virus in Solid Tumors
clinical-trials VT3989 TEAD Inhibitor Trial Opens to Mesothelioma Patients
legal Memorial Day 2026: Mesothelioma Still Isn't a VA Presumptive Disease
legal New York Jury Awards $25M in American Biltrite Asbestos Tile Case
clinical-trials NCI Registry Tracks 1,000 Mesothelioma Patients and Families With BAP1 Mutations (NCT03830229)
research Former South African Asbestos Miners Face Higher Mortality, UCT Study Finds
research 3D Mesothelioma Spheroids Reveal Why Chemo Often Fails
legal Georgia-Pacific Plans New Bankruptcy, Abandoning Bestwall
research ECOG Performance Status and Other Prognostic Factors in Mesothelioma: What the Numbers Mean for Your Options
research HIPEC and Cytoreductive Surgery for Peritoneal Mesothelioma: Who Qualifies and What to Expect
research Mesothelioma Clinical Trial Enrollment: A Practical Guide to Finding, Decoding, and Joining a Trial
research First-Line Mesothelioma Treatment in 2026: How to Choose Between Nivolumab+Ipilimumab and Pembrolizumab+Chemo
research Second-Line Mesothelioma Treatment: When First-Line Stops Working, What Comes Next
research Mesothelioma Survival Rates by Stage and Histology: What the Trial Data Actually Show
research Pleurectomy/Decortication vs Extrapleural Pneumonectomy: How Mesothelioma Surgery Decisions Are Made
research Stage 1 Pleural Mesothelioma: Operable Disease and the Multimodal Treatment Window
research Stage 2 Pleural Mesothelioma: Borderline-Operable Disease and the Induction-Therapy Decision
research Stage 3 Pleural Mesothelioma: Inoperable Disease, Immunotherapy, and the Active Trial Landscape
research Mesothelioma Chest Pain: How It Differs from Cardiac, Pleural, and Muscular Causes
research Mesothelioma Early Warning Signs: What to Notice 20 to 50 Years After Asbestos Exposure
research The Mesothelioma Symptom Timeline: From Latency to Late-Stage Progression
research Pleural Effusion in Mesothelioma: Drainage, Recurrence, and What It Means for Prognosis
research Stage 4 Mesothelioma: What to Expect and How Late-Stage Symptoms Are Managed
legal ADAO Sues EPA Over Missed Legacy Asbestos Rule Deadline
research Two Chemo-Combo Trials, Two Very Different Signals
research FDA Grants Orphan Drug Status to Orion's ODM-212
research V Foundation Awards $1 Million Grant to UH Cancer Center for BAP1 Mesothelioma Research
legal Asbestos Trust Funds for Louisiana Workers
legal Louisiana Mesothelioma Verdicts and Settlements: Avondale, Take-Home, and the Virile Share
research Louisiana Mesothelioma by the Numbers: Avondale, Refineries, and a One Year Deadline
legal Asbestos Trust Funds for New Jersey Workers
legal New Jersey Mesothelioma Verdicts and Settlements
legal Kroger, Contractor Pay $108K for Asbestos in Open Taylorville Store
research New Jersey Mesothelioma by the Numbers: Shipyards, Refineries, and a Century of Exposure
legal Asbestos Trust Funds for Washington Workers
legal Wisconsin Supreme Court Upholds $26.5M Pabst Asbestos Verdict
legal Washington Mesothelioma Verdicts and Settlements
research Shipyards, Paper Mills, and Vermiculite: Washington Mesothelioma by the Numbers
legal Asbestos Trust Funds for Alabama Workers
legal Asbestos Trust Funds for California Workers
legal Asbestos Trust Funds for Florida Workers
legal Asbestos Trust Funds for Georgia Workers
legal Asbestos Trust Funds for Indiana Workers
legal Asbestos Trust Funds for Iowa Workers
legal Asbestos Trust Funds for Michigan Workers
legal Asbestos Trust Funds for Missouri Workers
legal Asbestos Trust Funds for New York Workers
legal Asbestos Trust Funds for Ohio Workers
legal Asbestos Trust Funds for Pennsylvania Workers
legal Asbestos Trust Funds for Tennessee Workers
legal Asbestos Trust Funds for Wisconsin Workers
legal $115.6 Million Birmingham Verdict: Alabama Mesothelioma Cases
legal California Mesothelioma Verdicts and Settlements
legal Florida Mesothelioma Verdicts and Settlements
legal Georgia Mesothelioma Verdicts and Settlements
legal Asbestos Trust Funds for Illinois Workers
legal Indiana Mesothelioma Verdicts and Settlements
legal Iowa Mesothelioma Verdicts and Settlements
legal $3.9 Million and the Great Lakes: Michigan Mesothelioma Verdicts
legal $20 Million and Counting: Missouri Mesothelioma Verdicts
legal New York Mesothelioma Verdicts and Settlements
legal $27.5 Million and Counting: Ohio Mesothelioma Verdicts
legal Pennsylvania Mesothelioma Verdicts and Settlements
legal Tennessee Mesothelioma Verdicts and Settlements
legal Asbestos Trust Funds for Virginia Shipyard Workers and Navy Veterans
legal Wisconsin Mesothelioma Verdicts and Settlements
exposure Shipyards and Paper Mills: Georgia Asbestos Exposure Legacy
exposure Birmingham Steel, Mobile Ships: Alabama's Asbestos Legacy
exposure Chicago Steel Mills: The Southeast Side Asbestos Legacy
exposure Cleveland's Rust Belt Legacy: Steel Mills and Auto Plants That Exposed Thousands
exposure Manufacturing and Meatpacking: Iowa Asbestos Exposure Legacy
exposure Detroit's Auto Plants: The Asbestos Legacy of Ford, GM, and Chrysler
exposure Steel Mills and Auto Plants: Indiana Asbestos Exposure History
legal $45 Million and Counting: Illinois Mesothelioma Verdicts
exposure Shipyards and Bases: Florida Asbestos Exposure in Jacksonville, Tampa, and Beyond
exposure Shipyards, Refineries, and Geology: California Asbestos Exposure Legacy
exposure Paper Mills and Factories: Wisconsin Asbestos Exposure Legacy
exposure Chemical Plants and Oak Ridge: Tennessee Asbestos Exposure Legacy
exposure Brooklyn Navy Yard and the WTC: New York City Asbestos Exposure Legacy
exposure Steel Mills and Shipyards: Pennsylvania Asbestos Exposure Legacy
exposure St. Louis Manufacturing: A Century of Asbestos Exposure
legal Virginia Mesothelioma Verdicts and Settlements
research Alabama Mesothelioma by the Numbers: Birmingham Steel and Mobile Shipyards
research Most Cases in the Country: California Mesothelioma by the Numbers
research Second in the Nation (Cumulative): Florida Mesothelioma by the Numbers
research Georgia Mesothelioma Data: 651 Deaths Recorded 1999-2015 (CDC)
research Illinois Mesothelioma Statistics 2026: Cook County Verdicts, Exposure Industries, and Legal Deadlines
research Indiana Mesothelioma Rates: Steel Belt Legacy in the Data
research Twice the National Average: Iowa Mesothelioma by the Numbers
research 2,460 Diagnoses: Michigan Mesothelioma by the Numbers
research Missouri Mesothelioma by the Numbers: St. Louis and Kansas City
research New York Mesothelioma Cases and Statistics: 2026 Update
research Ohio Mesothelioma Statistics 2026: Cases, Deaths, and Industrial Exposure
research Second Highest Rate in the Nation: Pennsylvania Mesothelioma by the Numbers
research One-Year Filing Deadline: Tennessee Mesothelioma by the Numbers
research Virginia Mesothelioma by the Numbers: A Shipyard-State Profile
research Highest Rate in the Nation: Wisconsin Mesothelioma by the Numbers
research Asbestos Product Recalls 2026: A Running Global Tally
legal Asbestos Trust Funds for Maryland Workers
research Why Immunotherapy Works Differently in Peritoneal Mesothelioma
legal Maryland Mesothelioma Verdicts and Settlements
research Peritoneal vs Pleural Mesothelioma: A 2026 Data Comparison
news $850,000 Settlement for Families After Daycare Asbestos Exposure
research Maryland Mesothelioma by the Numbers: Sparrows Point, Shipyards, and Baltimore
research Six Years of Mesothelioma Immunotherapy: From First Approval to 2026
research Asbestos in American Schools: What the 2026 Data Shows
news Blood Clot Biomarkers Could Predict Risk After Mesothelioma Surgery
news Cohesin Gene Mutations Linked to Mesothelioma Recurrence After Surgery
news Asbestos in Children's Sand Products: Eight Countries, Zero US Action
legal Asbestos Trust Funds for Massachusetts Workers
legal Asbestos Trust Funds for Minnesota Workers
news First ROS1 Fusion in Peritoneal Mesothelioma Responds to Crizotinib
legal Massachusetts Mesothelioma Verdicts and Settlements
research The Mesothelioma Treatment Landscape in 2026
legal Minnesota Mesothelioma Verdicts and Settlements
research Shipyards, Mills, and Mesothelioma: Massachusetts by the Numbers
research Minnesota Mesothelioma by the Numbers: Taconite, Fiberboard, and the Iron Range
treatment First PITAC Procedure for Mesothelioma Performed in North America
legal Asbestos Trust Funds for Connecticut Workers
research MSK Study: Mesothelioma Rising in People Under 50, BAP1 Mutations a Key Factor
legal Asbestos Trust Funds for Oregon Workers
research TGF-β Combo Therapy Cuts Mesothelioma Tumor Growth by 70% in Lab Models
legal Connecticut Mesothelioma Verdicts and Settlements
legal Oregon Mesothelioma Verdicts and Settlements
research Connecticut Mesothelioma by the Numbers: Submarines, Brake Plants, and Talc
research Oregon Mesothelioma by the Numbers: A Pacific Northwest Industrial Legacy
exposure Canada Recalls Children's Craft Sand Over Asbestos
legal $30B in Trust Funds: How Much Has Been Paid Out
BREAKING J&J $950M Punitive Damages Overturned in Talc Case
research Mesothelioma Survival Rates by Treatment Type
research 8 Mesothelioma Trials Compared: Results Side by Side
news Asbestos in Craft Sand Closes 450+ Schools in ANZ
news $24.6M Default Judgment in Gold Bond Talc Case
news Pelvic Mesothelioma Shrinks 83% With Immunotherapy
news Durvalumab Plus Chemo Doubles Meso Survival
news UK Trials Proton Beam Therapy for Mesothelioma
news $1.56B Verdict Against J&J in Talc Mesothelioma Case
news Asbestos in Drinking Water: 5x Federal Limit in PA
news Hawaii Identifies L-BAM, Treatable Mesothelioma
research Mesothelioma Rates by State: 2026 Rankings
research Mesothelioma Risk by Occupation: 2026 Data
research Veterans and Mesothelioma: Risk by Military Branch
research CheckMate-743 at Five Years: 14% Still Alive
legal Banjima Launch $1.5B Asbestos Claim Over Wittenoom
legal Talc Claimants Challenge Revlon Bankruptcy Ruling
legal CA Court Rejects San Diego Workers Asbestos Suit
exposure UK Recalls 21+ Toys Over Asbestos in Sand Products
exposure DHS Workers Exposed to Asbestos at DC Demo Site
exposure WA Contractor Fined $200K for Asbestos Violations
legal Vanderbilt Minerals Files Bankruptcy Over Talc
treatment DREAM3R: Durvalumab Plus Chemo Falls Short
legal Smith Law Firm Sues Funders in Talc Cases
legal Philly Jury Finds J&J Liable in Talc Case, $250K
research Baylor-Duke NEMO Trial Tests Immuno Before Surgery
legal 9th Circuit Overturns $8M BNSF Libby Asbestos Verdict
research Blood Test Predicts Immunotherapy Response in Meso
legal $51M Avon Talc Verdict Upheld in Mesothelioma Case
legal $34.2M Verdict Against John Crane in Oregon Shipyard Case
research Mount Sinai P/D Surgery: Zero Mortality in Study
research UCSF Proposes First Peritoneal Meso Staging System
legal $18M Verdict in Florida Brake Dust Mesothelioma Lawsuit
legal Beasley Allen Disqualified From NJ Talc MDL
legal Asbestos Pipe Maker Sues Plaintiff Law Firm
legal $8M Verdict: J&J Talc Mesothelioma Case in Massachusetts
research ADI-PEG20 Phase 3 Trial Shows Promise: ATOMIC-Meso Results
research Ikena Halts IK-930 TEAD Inhibitor Program
legal J&J Texas Two-Step Fraud Lawsuit Dismissed
research UV1 Vaccine Gets FDA Fast Track for Mesothelioma
clinical-trials Atezolizumab Trial: Phase 1 Study for Mesothelioma
clinical-trials Atezolizumab Phase 3 Trial for Pleural Mesothelioma
clinical-trials Atezolizumab Phase 1 Trial for Pleural Mesothelioma
clinical-trials A2 Bio BASECAMP-1 Screening Study (NCT04981119)
clinical-trials A2 Bio EVEREST-2 CAR-T Phase 1/2 Trial (NCT06051695)
clinical-trials UTC CAR-T Phase 1 Trial (NCT06256055)
clinical-trials CAR-T Trial: Phase 1 Study for Pleural Mesothelioma
clinical-trials NCI TNhYP218 CAR-T Phase 1 Trial (NCT06885697)
clinical-trials Immunotherapy Trial: Phase 1 Study for Mesothelioma
clinical-trials NCI HIPEC Phase 1 Trial (NCT04847063)
clinical-trials NCI HIPEC Phase 2 Trial (NCT05001880)
clinical-trials MSK HIPEC Phase 2 Trial (NCT06057935)
clinical-trials TIL Cell Therapy Phase 2 Trial (NCT03935893)
clinical-trials BWH MAGIC AKI Phase 2 Trial (NCT05730816)
clinical-trials MSK Sacituzumab Govitecan Phase 2 Trial (NCT06477419)
clinical-trials NCI FAPI-74 PET Imaging Phase 2 Trial (NCT06503146)
news Mesothelioma Clinical Trials Recruiting in 2026
clinical-trials Nivolumab + Ipilimumab Phase 2 Trial for Mesothelioma
clinical-trials Photodynamic Therapy + Nivolumab Phase 2 Trial (NCT04400539)
clinical-trials Nivolumab + Ipilimumab Phase 1/2 Trial (NCT07121374)
clinical-trials VM Oncology Pembrolizumab Phase 1/2 (NCT03556228)
clinical-trials MSK Pembrolizumab Phase 1 Trial (NCT04897022)
clinical-trials Pembrolizumab, Chemo and Lenvatinib Phase 2 Trial for Pleural Mesothelioma
clinical-trials Volrustomig (MEDI5752) Phase 3 Trial in Pleural Mesothelioma (NCT06097728)
research Hopkins: Immunotherapy + Surgery Extends Survival
legal $20M Verdict Against J&J in Florida Mesothelioma Case
news The Asbestos Cover-Up: What the Industry Knew in 1930
exposure Your Mechanic May Be Breathing Asbestos Right Now
news About 2,500 Americans Die From Mesothelioma Each Year
exposure The Hidden Danger in Your Ceiling
exposure Advocates Sue for East Wing Asbestos Records
research New Review Maps BAP1 Loss in Mesothelioma
exposure UK Recalls Children's Play Sand After Asbestos Found
news UK, EU Split on Talc Cancer Classification
legal $42.6M J&J Talc Verdict in Massachusetts
exposure Montana Windstorm Scatters School Asbestos
BREAKING Cell Therapy Shrinks Tumors in 63%
exposure Cassiar: The Town That Asbestos Built
legal Vi-Jon Talc Mesothelioma Case Settles in California
exposure Cold Lake School Closes After Asbestos Found
asbestos Malaysia Asbestos Ban Push Intensifies
legal $25M Verdict Against J&J in Connecticut Mesothelioma Case
legal U.S. Chamber Urges 5th Circuit to Vacate EPA Asbestos Ban
research Measles Vaccine Gets FDA Orphan Drug for Meso
legal Virginia Supreme Court: Shipyards Owe Duty to Families (Quisenberry, 2018)
legal J&J Talc Verdicts Top $2.5B in 2025
news Mesothelioma Treatment Advances: 2025
BREAKING Record $1.56B Verdict Against J&J in Talc
legal $65.5M Verdict Against J&J in Minnesota Mesothelioma Case
legal $40M Verdict Against J&J in California Ovarian Cancer Case
research Drug Combo Achieves 60% Response Rate
news FDA Withdraws Talc Asbestos Testing Rule
treatment One Drug Halted, Another Advances
research Cyncado to Test TT-4 in Australian Meso Trial
legal Judge Allows Experts in 67,500 Talc Cases
exposure Japan Banned Asbestos in 2006, Cases Rise
exposure Minot AFB Missile Crews Face Asbestos Risk
research Mesothelioma Survival: 18-Year Survivor's Story
BREAKING $966M Verdict: J&J Concealed Talc Asbestos Risk
legal $966M Verdict Against J&J in California Mesothelioma Case
news Mesothelioma Awareness Day: September 26
research Mesothelioma Treatment: Hopkins Immunotherapy Trial
treatment VT3989 Doubles Time Without Progression
treatment Hopkins: Pre-Surgery Immunotherapy Success
treatment Trial Tests Immunotherapy Before Surgery
research IMPALA Trial: Light Therapy for Mesothelioma
legal $3.3M Ford Asbestos Brake Verdict Upheld in NY
exposure Paramount Studios Faces Asbestos Suits
legal $117M Asbestos Verdict Sets New York Record
news Asbestos Disclosure Bill H.R.4247
exposure Libby, Montana: America's Deadliest Town
treatment Dual-Target Immunotherapy Shows 52% Response
news UK Commits £1.2B for Asbestos Removal
exposure UK Has World's Highest Meso Rates
exposure Canada Banned Asbestos, Cases Still Rise
treatment FDA Approves Opdivo Qvantig for Mesothelioma
exposure Utah Windstorm Spreads Mine Asbestos
treatment KEYNOTE-483: Keytruda Combo Approved
BREAKING FDA Approves Keytruda Combo for Mesothelioma
news 9/11 Mesothelioma Crisis Still Unfolding
research DENIM Trial: Vaccine Did Not Extend Survival
exposure WHO Classifies Talc as Probable Carcinogen
research MARS 2: Chemo Outperformed Surgery
exposure EPA Bans Chrysotile: First U.S. Asbestos Ban
treatment ATOMIC-Meso: Quadrupled 3-Year Survival
treatment CONFIRM Trial: Nivolumab Extends Survival in Relapsed Mesothelioma
news 2023 Mesothelioma Verdicts: $40M+ Awards
news Court Rejects J&J's 2nd Talc Bankruptcy
treatment SynKIR-110 CAR-T Gets FDA Fast-Track
exposure J&J Discontinues Talc Baby Powder
news EPA Proposes Chrysotile Asbestos Ban
news J&J Creates LTL to Shield Talc Liability
legal J&J's Texas Two-Step: 3 Failed Attempts
news FDA OKs Opdivo+Yervoy for Mesothelioma
treatment CheckMate-743: Immunotherapy Beats Chemo
legal $750M Verdict Against J&J in New Jersey Mesothelioma Cases
legal Chris Placitella on 40 Years of Asbestos Trials
exposure FDA Finds Asbestos in J&J Baby Powder
news FDA Approves Optune Lua for Mesothelioma
exposure FDA Finds Asbestos in Claire's Makeup
legal $4.69B Verdict Against J&J in St. Louis Talc Case
exposure Brazil Bans Asbestos in Landmark 2017 Ruling
exposure Lautenberg Act: Path to Asbestos Ban
news Zadroga Act: Permanent Care for 9/11 Responders
Featured Coverage
In-depth reporting, data analysis, and investigations
DATA
Talcum Powder Crisis By the Numbers
The talc crisis by the numbers: about 90,000 lawsuits, $10B+ in verdicts, and decades of corporate knowledge. The data tells the story.